| 210.57 -2.99 (-1.4%) | 08-24 10:01 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 253.52 | 1-year : | 296.11 |
| Resists | First : | 217.05 | Second : | 253.52 |
| Pivot price | 201.87  |
|||
| Supports | First : | 196.78 | Second : | 184.25 |
| MAs | MA(5) : | 211.16 |
MA(20) : | 198.46 |
| MA(100) : | 180.65 |
MA(250) : | 169.55 |
|
| MACD | MACD : | 6.2 |
Signal : | 4.8 |
| %K %D | K(14,3) : | 83.5 |
D(3) : | 88.7 |
| RSI | RSI(14): 66.1 |
|||
| 52-week | High : | 217.05 | Low : | 136.74 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ IBB ] has closed below upper band by 20.8%. Bollinger Bands are 99.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 215.85 - 216.71 | 216.71 - 217.44 |
| Low: | 208.69 - 209.75 | 209.75 - 210.66 |
| Close: | 211.74 - 213.46 | 213.46 - 214.94 |
The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.
Fri, 21 Aug 2026
IBB PE Ratio & Valuation, Is IBB Overvalued - Intellectia AI
Wed, 19 Aug 2026
Ishares Biotech ETF up 3.2%, State Street Spd - Moomoo
Tue, 18 Aug 2026
iShares Biotechnology ETF (NASDAQ: IBB) Share Price, IBB Stock News, IBB Share Price & Updates - Kalkine
Sun, 12 Jul 2026
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance? - The Motley Fool
Sat, 04 Jul 2026
Vanguard Health Care vs. iShares Biotech: How Do These ETFs Stack Up? - The Motley Fool
Mon, 29 Jun 2026
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|